These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
420 related articles for article (PubMed ID: 29158264)
1. Azole resistance in a Khandelwal NK; Chauhan N; Sarkar P; Esquivel BD; Coccetti P; Singh A; Coste AT; Gupta M; Sanglard D; White TC; Chauvel M; d'Enfert C; Chattopadhyay A; Gaur NA; Mondal AK; Prasad R J Biol Chem; 2018 Jan; 293(2):412-432. PubMed ID: 29158264 [TBL] [Abstract][Full Text] [Related]
2. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Sanglard D; Kuchler K; Ischer F; Pagani JL; Monod M; Bille J Antimicrob Agents Chemother; 1995 Nov; 39(11):2378-86. PubMed ID: 8585712 [TBL] [Abstract][Full Text] [Related]
3. The putative ABC transporter encoded by the orf19.4531 plays a role in the sensitivity of Candida albicans cells to azole antifungal drugs. Jiang L; Xu D; Chen Z; Cao Y; Gao P; Jiang Y FEMS Yeast Res; 2016 May; 16(3):. PubMed ID: 26975389 [TBL] [Abstract][Full Text] [Related]
4. Unmasking of CgYor1-Dependent Azole Resistance Mediated by Target of Rapamycin (TOR) and Calcineurin Signaling in Candida glabrata. Kumari S; Kumar M; Esquivel BD; Wasi M; Pandey AK; Kumar Khandelwal N; Mondal AK; White TC; Prasad R; Gaur NA mBio; 2022 Feb; 13(1):e0354521. PubMed ID: 35038899 [TBL] [Abstract][Full Text] [Related]
5. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms. Sanglard D; Coste AT Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310 [TBL] [Abstract][Full Text] [Related]
6. Beauvericin Potentiates Azole Activity via Inhibition of Multidrug Efflux, Blocks Candida albicans Morphogenesis, and Is Effluxed via Yor1 and Circuitry Controlled by Zcf29. Shekhar-Guturja T; Tebung WA; Mount H; Liu N; Köhler JR; Whiteway M; Cowen LE Antimicrob Agents Chemother; 2016 Dec; 60(12):7468-7480. PubMed ID: 27736764 [TBL] [Abstract][Full Text] [Related]
7. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. Sanglard D; Ischer F; Monod M; Bille J Microbiology (Reading); 1997 Feb; 143 ( Pt 2)():405-416. PubMed ID: 9043118 [TBL] [Abstract][Full Text] [Related]
8. ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates. Holmes AR; Lin YH; Niimi K; Lamping E; Keniya M; Niimi M; Tanabe K; Monk BC; Cannon RD Antimicrob Agents Chemother; 2008 Nov; 52(11):3851-62. PubMed ID: 18710914 [TBL] [Abstract][Full Text] [Related]
9. The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates. Holmes AR; Keniya MV; Ivnitski-Steele I; Monk BC; Lamping E; Sklar LA; Cannon RD Antimicrob Agents Chemother; 2012 Mar; 56(3):1508-15. PubMed ID: 22203607 [TBL] [Abstract][Full Text] [Related]
10. Azole susceptibility and transcriptome profiling in Candida albicans mitochondrial electron transport chain complex I mutants. Sun N; Fonzi W; Chen H; She X; Zhang L; Zhang L; Calderone R Antimicrob Agents Chemother; 2013 Jan; 57(1):532-42. PubMed ID: 23147730 [TBL] [Abstract][Full Text] [Related]
11. Vacuolar Sequestration of Azoles, a Novel Strategy of Azole Antifungal Resistance Conserved across Pathogenic and Nonpathogenic Yeast. Khandelwal NK; Wasi M; Nair R; Gupta M; Kumar M; Mondal AK; Gaur NA; Prasad R Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642932 [TBL] [Abstract][Full Text] [Related]
12. Divergent functions of three Candida albicans zinc-cluster transcription factors (CTA4, ASG1 and CTF1) complementing pleiotropic drug resistance in Saccharomyces cerevisiae. Coste AT; Ramsdale M; Ischer F; Sanglard D Microbiology (Reading); 2008 May; 154(Pt 5):1491-1501. PubMed ID: 18451058 [TBL] [Abstract][Full Text] [Related]
13. The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents. Sanglard D; Ischer F; Calabrese D; Majcherczyk PA; Bille J Antimicrob Agents Chemother; 1999 Nov; 43(11):2753-65. PubMed ID: 10543759 [TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India. Mane A; Vidhate P; Kusro C; Waman V; Saxena V; Kulkarni-Kale U; Risbud A Mycoses; 2016 Feb; 59(2):93-100. PubMed ID: 26648048 [TBL] [Abstract][Full Text] [Related]
15. Vanillin confers antifungal drug synergism in Candida albicans by impeding CaCdr2p driven efflux. Saibabu V; Fatima Z; Singh S; Khan LA; Hameed S J Mycol Med; 2020 Apr; 30(1):100921. PubMed ID: 31937429 [TBL] [Abstract][Full Text] [Related]
16. Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors. Sanglard D; Ischer F; Monod M; Bille J Antimicrob Agents Chemother; 1996 Oct; 40(10):2300-5. PubMed ID: 8891134 [TBL] [Abstract][Full Text] [Related]
17. Learning the ABC of oral fungal drug resistance. Cannon RD; Holmes AR Mol Oral Microbiol; 2015 Dec; 30(6):425-37. PubMed ID: 26042641 [TBL] [Abstract][Full Text] [Related]
18. Rationally designed transmembrane peptide mimics of the multidrug transporter protein Cdr1 act as antagonists to selectively block drug efflux and chemosensitize azole-resistant clinical isolates of Candida albicans. Maurya IK; Thota CK; Verma SD; Sharma J; Rawal MK; Ravikumar B; Sen S; Chauhan N; Lynn AM; Chauhan VS; Prasad R J Biol Chem; 2013 Jun; 288(23):16775-16787. PubMed ID: 23592791 [TBL] [Abstract][Full Text] [Related]
19. Antagonism of azole activity against Candida albicans following induction of multidrug resistance genes by selected antimicrobial agents. Henry KW; Cruz MC; Katiyar SK; Edlind TD Antimicrob Agents Chemother; 1999 Aug; 43(8):1968-74. PubMed ID: 10428921 [TBL] [Abstract][Full Text] [Related]
20. Impact of Farnesol as a Modulator of Efflux Pumps in a Fluconazole-Resistant Strain of Černáková L; Dižová S; Gášková D; Jančíková I; Bujdáková H Microb Drug Resist; 2019; 25(6):805-812. PubMed ID: 30785845 [No Abstract] [Full Text] [Related] [Next] [New Search]